QualityStocksNewsBreaks Archives - Page 744 of 1498

ThursdayMay 20, 2021 12:25 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Strengthens IP Portfolio with 12th Patent Filing

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has filed a provisional patent application in support of its ongoing drug candidate programs. The patent is the 12th patent filed by the company. In the announcement, the company noted that the application discloses novel compositions anticipated to have improved pharmacokinetic profiles while retaining significant efficacy measures of the original molecules; the patent also discusses innovative methods of deploying the novel compositions with faster therapeutic onset of Cybin’s psychedelic tryptamine, while reducing psychedelic side effects and decreasing duration of the therapeutic effect thereof. In addition, the patent…

ThursdayMay 20, 2021 12:25 pm

QualityStocksNewsBreaks – Amazon.com Inc. (NASDAQ: AMZN) Featured in Simply Wall St Journal

Amazon (NASDAQ: AMZN), an American multinational technology company focused on e-commerce, cloud computing, digital streaming and artificial intelligence, was featured in this week’s Simply Wall St Journal. The piece reviews Amazon’s impressive story of innovation, growth and dominance and, after trouncing expectations for its Q1 results, provides a view of what analysts are now expecting. “Following the latest results, Amazon's 43 analysts are now forecasting revenues of US$489.7b in 2021. This would be a solid 17% improvement in sales compared to the last 12 months. Per-share earnings are expected to increase 2.8% to US$55.13,” the publication reads. “Before this earnings…

ThursdayMay 20, 2021 12:14 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leverages Key Initiatives to Advance Drug Candidates

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a pharmaceutical company focused on developing clinical-stage compounds for diseases with high unmet medical needs. “Tryp’s current focus is on advancing its two drug development platforms: its Psilocybin-for-Neuropsychiatric Disorders (‘PFN’(TM)) program targeting fibromyalgia, eating disorders and chronic pain conditions; and razoxane for soft tissue sarcomas,” reads a recent article regarding Tryp’s positioning. The piece also discusses the company’s three strategic initiatives. “Develop” is its first initiative, under which Tryp intends to utilize FDA’s 505(b)(2) regulatory pathway with available third-party preclinical data to shorten the timelines and lower the cost of its development programs.…

ThursdayMay 20, 2021 12:11 pm

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Presentation Schedule for June Investor Conferences

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced that it will present at two investor conferences slated to take place in June. These include scheduled presentations, as detailed in the update, at the Jefferies Virtual Healthcare Conference and the William Blair 41st Annual Virtual Growth Stock Conference. Interested parties should visit the sponsor’s conference website for more information regarding these events. To view the full press release, visit https://ibn.fm/WkY5l About VistaGen Therapeutics Inc. VistaGen is…

ThursdayMay 20, 2021 12:08 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Enters Strategic Partnership with Grocery Supply Warehouse

Kaival Brands (OTCQB: KAVL) today announced its entry into a customer agreement with Grocery Supply Warehouse (“GSW”), a master distributor representing dozens of wholesalers with a combined network of over 26,000 grocery and convenience stores. Kaival Brands is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI (R) Stick, which is intended exclusively for adults 21 and over. Under the agreement, GSW has placed purchased orders in an aggregate amount of $22.4 million with Kaival Brands to distribute Bidi Vapor products throughout its network to certain wholesale and retail store customers. “The partnership with GSW represents…

ThursdayMay 20, 2021 11:48 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary Covid-ID Lab to Launch in Germany

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that Marx Pharma GmbH, the company’s distribution, storage and logistics partner, is launching Covid-ID Lab, XPhyto’s 25-minute SARS-CoV-2 (COVID-19) RT-PCR test system in Germany; the product will launch on May 25. The announcement noted that the proprietary Covid-ID Lab will be priced within the range of commonly available COVID-19 PCR test products already on the market and that initial manufacturing capacity has been determined; additional manufacturing capacity is also available if needed. XPhyto’s Covid-ID Lab requires only a 20-minute PCR run…

ThursdayMay 20, 2021 11:29 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Issues Update Regarding Potential Acquisition, Joint Venture with Canadian Partner

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today issued an update to its March 1, 2021, announcement that it had been approached by a Canadian cannabis company to enter into discussions concerning a potential acquisition transaction. The discussions evolved to include development of a memorandum of understanding (“MOU”) setting forth terms under which the parties could enter into a joint venture to jointly manufacture, distribute and market Grapefruit’s products, including, but not limited to, Grapefruit’s patented disruptive Hourglass(TM) THC/cannabinoid time-release delivery cream throughout Canada. A March 8 announcement indicated that the Canadian partner noticed a special…

ThursdayMay 20, 2021 10:48 am

QualityStocksNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Announces Timing of Corporate Name Change, Share Consolidation

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF) today announced that, pursuant to the shareholder approval obtained at its annual and special meeting (“AGM”) held on May 10, 2021, the company is enacting the consolidation of its common shares on the basis of one (1) post-consolidation common share for every twenty-three (23) pre-consolidation common shares (the "consolidation"), as well as the change of its name from “Golden Leaf Holdings Ltd.” to “Chalice Brands Ltd.” (the “name change”). According to the update, the consolidation and name change will take effect on Tuesday, May 25, 2021, and the company's common shares will also…

ThursdayMay 20, 2021 10:23 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR) (FSE: N29) to Host LiveX Showcase Event Featuring Guest Speaker Gary Vee

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR) (FSE: N29), has unveiled its newest innovation. Nextech AR LiveX, the company’s digital experience platform is designed to deliver great customer experiences at scale with the power of augmented reality (“AR”). The offering is an open, extensible platform that provides for AR experiences, e-commerce, advertising and products. In the announcement, the company noted that LiveX offered a wide array of AR capabilities, including the general availability of AR live-streaming hologram, real-time customer data analytics and innovative ways to customize digital and hybrid experiences; the company also noted that it plans on…

ThursdayMay 20, 2021 10:16 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Enters Agreement with Leading Mexican Academic Research Institution to Advance ECS Research

Green Hygienics Holdings (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, announced that it partnered with Cinvestav, the Center for Research and Advanced Studies of the National Polytechnic Institute (Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional). The scientific research collaboration agreement is aimed at advancing R&D efforts through the characterization and development of cannabinoid-based products targeting endocannabinoid system (“ECS”) deficiencies in both animals and humans. Cinvestav is a leading Mexican multidisciplinary scientific research institution, ranking fourth among research centers in Latin…

Site Search

Company Search

Category: QualityStocksNewsBreaks